CSL is set to become the second largest flu vaccine business in the world with the acquisition of a subsidiary of Swiss pharmaceutical multinational...
Manufacturers are facing an increasingly volatile environment, where rapid changes in demand, supply chain disruptions, and continued cost pressures are transforming the way products are planned, made, and delivered.